The three regulatory frameworks and what they require of the machine<\/h2>\n
21 CFR Part 211, EU GMP Annex 15, ICH Q7 \u2014 equipment-level obligations<\/p>\n<\/div>\n<\/div>\n
The US FDA’s 21 CFR Part 211 (Current Good Manufacturing Practice for Finished Pharmaceuticals) addresses equipment at Subpart D (\u00a7211.63\u2013\u00a7211.72). Section 211.65 requires that equipment surfaces that contact components, in-process materials, or drug products shall not be reactive, additive, or absorptive so as to alter the safety, identity, strength, quality, or purity of the drug product. For a blow molding machine, the “surfaces that contact” the product are the blow air path (from the compressor outlet to the container interior), the stretch rod surface, and the preform transport mechanism at the neck contact zone. Each of these must be made of materials with documented inertness to the pharmaceutical formulation and cleaning agents used at the site.<\/p>\n
Section 211.68 requires that automatic, mechanical, and electronic equipment is routinely calibrated, inspected, or checked according to a written program, and that records of calibration and maintenance are kept. For a pharmaceutical blow molding machine, this translates to: calibration schedules for all thermocouple sensors (barrel zones, conditioning station), pressure transducers (blow air), flow meters (cooling water), and servo encoder systems; documented inspection intervals for mechanical components; and a maintenance log that connects each record to a specific machine serial number and production date. The HGA.ES series PLC maintains these records in a structured log format exportable in CSV and OPC-UA \u2014 formats compatible with major pharmaceutical LIMS and MES systems without bespoke integration.<\/p>\n
EU GMP Annex 15 (Qualification and Validation, 2015 revision) formalizes the IQ\/OQ\/PQ framework that the FDA’s process validation guidance (2011) also references. Annex 15 Section 4 states that the extent of qualification and validation should be determined using a risk-based approach \u2014 which in practice means that for pharmaceutical container production equipment, the qualification protocol is proportionate to the criticality of the machine’s contribution to container quality. Because wall thickness, neck finish dimensions, and AA migration are all properties that the machine directly controls, a blow molding machine for pharmaceutical bottles is treated as a critical utility equivalent to a filling machine in the risk classification. This means IQ, OQ, and PQ are all mandatory \u2014 not optional.<\/p>\n
![\"GMP](\"https:\/\/ever-powers.com\/wp-content\/uploads\/2026\/08\/GMP-Regulations-and-Equipment-Compliance-Framework-300x169.webp\" "\\"\\"")
<\/p>\n
ICH Q7 (Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients) Section 5 contains the GMP requirements for equipment used in API and intermediate manufacture. Although the HGA.ES machine is used for finished product container production rather than API manufacture, many pharmaceutical packaging operations apply ICH Q7 equipment principles by analogy, particularly Section 5.4 on equipment cleanliness and Section 5.40 on calibration. The practical difference between ICH Q7 and 21 CFR Part 211 for machine qualification purposes is primarily in the documentation format, not the substantive requirements.<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
| Framework<\/th>\n | Geography<\/th>\n | Equipment-relevant requirements<\/th>\n | Documentation standard<\/th>\n<\/tr>\n<\/thead>\n | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 CFR Part 211<\/td>\n | United States (FDA)<\/td>\n | Equipment qualification IQ\/OQ\/PQ; written calibration and maintenance procedures; product-contact material certification (\u00a7211.65); calibration records (\u00a7211.68)<\/td>\n | FDA Process Validation Guidance (2011); ASTM E2500-17<\/td>\n<\/tr>\n | ||||||||||||||||
| EU GMP Annex 15<\/td>\n | European Union (EMA)<\/td>\n | Risk-based equipment qualification; change control for equipment modifications; ongoing process verification (OPV) after PQ completion<\/td>\n | EMA Annex 15 (2015 revision); GAMP 5 (ISPE)<\/td>\n<\/tr>\n | ||||||||||||||||
| ICH Q7<\/td>\n | Global (API\/intermediate manufacturers; packaging by analogy)<\/td>\n | Equipment design to prevent contamination (Sec 5.1); written cleaning procedures (Sec 5.4); calibration program with records (Sec 5.40\u20135.45)<\/td>\n | ICH Q7A Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n <\/p>\n \n 02<\/div>\n \n GMP machine design requirements: four areas where specification matters<\/h2>\nProduct-contact materials, particulate control, CPP monitoring, and lubrication \u2014 with HGA.ES compliance specifics<\/p>\n<\/div>\n<\/div>\n <\/div>\n Product-contact surface materials.<\/strong> The blow air circuit is the most frequently overlooked contact surface in a pharmaceutical bottle production audit. In a standard blow molding machine for food or consumer applications, the blow air circuit \u2014 high-pressure manifolds, distribution pipes, blow nozzles \u2014 is made of general-purpose steel or aluminium alloy. In a pharmaceutical installation, any surface that the blow air passes over before entering the container interior is considered a potential source of contamination. The HGA.ES series uses 316L stainless steel for all blow air circuit components from the machine inlet to the blow nozzle. Grade 316L (UNS S31603) is specified rather than 304 because of its lower carbon content (\u22640.03% vs \u22640.08% for 304), which eliminates the sensitization risk during welding \u2014 relevant for the manifold weld joints in the blow circuit. Material compliance certificates (Mill Test Certificates, EN 10204 Type 3.1) are available for all 316L components as part of the IQ documentation package.<\/p>\n The stretch rod \u2014 which contacts the preform interior during axial stretching \u2014 is coated with PTFE (polytetrafluoroethylene) at the preform-contact zone. PTFE is chemically inert to all pharmaceutical formulations in scope for PET container production, and it can be cleaned with 70% isopropyl alcohol or with aqueous peracetic acid at concentrations up to 0.5% without chemical attack. The PTFE coating is applied to a thickness of 100\u2013200 \u00b5m and is replaced on a scheduled maintenance interval (typically after every 2,000 operational hours) \u2014 replacement intervals are embedded in the machine’s preventive maintenance schedule. Preform holder inserts at the blow station are hard-anodized aluminium (anodized to Type III per MIL-A-8625F, minimum 25 \u00b5m oxide layer) \u2014 non-reactive, non-contaminating, and wipe-cleanable with pharmaceutical-grade solvents. Conditioning chain holders that contact the preform neck exterior are machined from PEEK (polyetheretherketone, Victrex 450G or equivalent) \u2014 a material with a continuous service temperature of 250\u00b0C, stable to quaternary ammonium compound disinfectants, peracetic acid, chlorine dioxide, and hydrogen peroxide vapor at concentrations used in pharmaceutical cleanroom decontamination.<\/p>\n Particulate control from mechanical wear.<\/strong> Metal particulates generated by mechanical wear of machine components and entering a container interior is classified as a product contamination event under GMP, requiring batch segregation, investigation, and potentially a regulatory notification. The primary sources of metal particulate in a conventional blow molding machine are open guide rail slides (where the mold carriage rides on exposed steel rails) and hydraulic clamping cylinders (where rod seals degrade over time and generate polymer and metal particles). The HGA.ES series eliminates both: clamping and transfer axes use enclosed linear bearing assemblies with sealed housings \u2014 no open metal-on-metal sliding contact is exposed to the production environment above the blow station. The clamping mechanism uses a servo-driven toggle system with sealed ball screw drives and enclosed recirculating ball nut assemblies. The ball screws are grease-lubricated with an NSF H1 registered grease (per requirement 4 below) and the lubrication cavities are sealed \u2014 lubricant does not migrate to the exterior of the assembly. For ISO 14644-1 Class 7 cleanroom installation, the machine electrical cabinet is separately housed and positively pressured via a HEPA-filtered air supply line, preventing contaminated room air from cycling through cabinet thermal events into the production environment.<\/p>\n Critical process parameter monitoring and batch record generation.<\/strong> The CPPs for an ISBM pharmaceutical bottle machine divide into two groups: injection station parameters (barrel zone temperatures, injection pressure, injection speed, holding pressure, holding time, back pressure, screw recovery speed, mold cooling water temperature at injection mold) and blow station parameters (conditioning station lamp outputs per zone, conditioning dwell time, pre-blow pressure and timing, main blow pressure and timing, blow hold duration, mold cooling water temperature and flow rate at blow mold, and stretch rod position). The HGA.ES PLC logs all of these at cycle level \u2014 meaning one data record per machine cycle, not averaged over a time interval \u2014 and stores the rolling dataset in onboard memory for a minimum of 72 hours of continuous production at the machine’s rated cycle rate. For a 6-cavity HGA.ES-6C76 running at 7,200 bph, 72 hours of data represents approximately 518,400 cycle records. This data is accessible via the HMI and exportable via USB drive, Ethernet (FTP), or OPC-UA to a plant historian, LIMS, or MES. Alarm events \u2014 any excursion of a CPP outside the set-point range \u2014 are logged with timestamp (to the second), the specific parameter that alarmed, the measured value, and the set-point limits. The alarm log is a separate file from the process data log and is maintained independently to prevent overwriting by normal production data.<\/p>\n Lubrication control.<\/strong> ICH Q7 Section 5.42 states that lubricants and other materials used in equipment shall not come into contact with intermediates or APIs unless their use is controlled and they have been shown not to alter quality. For pharmaceutical bottle production, the relevant standard is NSF International’s H1 category \u2014 lubricants acceptable for incidental food (or in this context, pharmaceutical-container) contact. All lubrication points in the preform transport zone, transfer arm pivot bearings, mold guide rail linear bearings, blow station mechanism, and stretch rod drive mechanism on the HGA.ES series are lubricated exclusively with NSF H1 registered lubricants. The specific lubricant grades used are identified in the machine’s IQ documentation package with their NSF H1 registration numbers \u2014 cross-referenced to the lubrication point diagram in the maintenance manual. Lubrication frequency for each point is programmed into the PLC maintenance scheduler: the machine alerts the operator on the HMI at each scheduled interval, and the maintenance technician’s confirmation of lubrication completion is logged by the PLC with operator ID (badge or login code) and timestamp \u2014 creating a traceable maintenance record without requiring a separate paper-based system.<\/p>\n <\/p>\n <\/p>\n What each phase covers \u2014 and what the machine manufacturer must supply vs. what the user site generates<\/p>\n<\/div>\n<\/div>\n The IQ (Installation Qualification) phase verifies that the machine as installed matches the design specification as ordered. For a pharmaceutical bottle blow molding machine, IQ covers: verification of machine model, serial number, and build specification against the purchase order and design specification; physical inspection of product-contact surface materials against material certificates; calibration status verification for all instruments against their calibration certificates (each thermocouple, pressure transducer, flow meter, and servo encoder in the system should arrive with a current calibration certificate traceable to a national standard \u2014 NIST in the US, NPL in the UK, PTB in Germany); verification that utility connections (compressed air, chilled water, electrical supply) meet the machine’s specified requirements and that the actual utility values fall within the machine’s specified operating range; and documentation of the machine’s physical location in the production area including room number, floor, building, and GPS coordinates if required by the site’s validation master plan.<\/p>\n The IQ documentation package that Ever-Power supplies with an HGA.ES medicine bottle machine includes: machine design specification document; wiring diagrams (as-built, not as-designed); pneumatic schematic (as-built); bill of materials for all product-contact components, including material grade and supplier; material certificates (EN 10204 Type 3.1) for 316L stainless steel components; supplier declarations of conformity for PTFE, PEEK, and anodized aluminium components; instrument calibration certificates for all sensors and transducers; NSF H1 registration confirmation for all lubricants specified in the maintenance manual; and Factory Acceptance Test (FAT) records demonstrating that the machine was operated at target cycle rate and produced containers within dimensional specification before shipment. The completeness of this package significantly affects the IQ timeline at the user site \u2014 incomplete documentation is the most common cause of IQ phase overrun.<\/p>\n The OQ (Operational Qualification) phase verifies that the machine operates within its specified ranges across all CPPs. OQ for a pharmaceutical bottle blow molding machine is executed with the production mold installed and the target preform loaded but before committing to commercial production. The OQ protocol tests each CPP at its nominal set point, at the upper end of its acceptable range, and at the lower end \u2014 to confirm that the machine can actually maintain specification at both limits. For the HGA.ES series: barrel zone temperature control is verified at \u00b12\u00b0C of set point across all zones simultaneously; blow pressure is verified at \u00b10.5 kg\/cm\u00b2 of set point under full cycling at production speed; clamping position repeatability is verified at \u00b10.1mm cycle-to-cycle over a minimum 100-cycle test; cooling water temperature at the mold inlet is verified at \u00b11\u00b0C of set point under load; and all alarm functions are challenge-tested by deliberately introducing CPP excursions to confirm that alarms fire at the correct threshold and that the machine either self-corrects or stops within the specified response time.<\/p>\n The PQ (Performance Qualification) phase demonstrates that the machine consistently produces containers meeting all Critical Quality Attributes (CQAs) across three consecutive production runs. PQ is run at full commercial production speed with the commercial resin and preform specification. For a 100ml pharmaceutical medicine bottle as an example: the CQAs include body zone wall thickness (nominal 0.30mm, \u00b10.04mm specification), neck finish T-dimension (\u00b10.10mm), E-dimension (\u00b10.10mm), seating surface flatness (\u00b10.08mm), container weight (nominal value \u00b12.5%), top-load resistance (minimum specification per container design), and acetaldehyde (AA) content in the container headspace (typically \u226410 \u00b5g\/l for oral pharmaceutical applications). Each CQA must achieve Cpk \u2265 1.33 across the three PQ runs \u2014 meaning the process capability index is calculated from the combined dataset of all three runs, not from each run individually. PQ run size is typically 1,000\u20133,000 containers depending on the site’s validation master plan. Total IQ\/OQ\/PQ timeline from machine installation to commercial batch release: 8\u201314 weeks, with IQ taking 2\u20133 weeks, OQ 3\u20134 weeks, and PQ 3\u20135 weeks.<\/p>\n Installation Qualification \u2014 2\u20133 weeks<\/strong><\/p>\n Design specification vs. as-built verification; EN 10204 Type 3.1 material certificates for 316L SS components; PTFE, PEEK, anodized Al supplier declarations; instrument calibration certificates (NIST\/NPL\/PTB traceable); NSF H1 lubricant registration confirmation; FAT records; utility connections within specified range; equipment location documentation.<\/p>\n<\/div>\n<\/div>\n Operational Qualification \u2014 3\u20134 weeks<\/strong><\/p>\n CPP range verification: barrel temperature \u00b12\u00b0C; blow pressure \u00b10.5 kg\/cm\u00b2; clamping position \u00b10.1mm over 100 cycles; cooling water \u00b11\u00b0C at mold inlet; alarm function challenge tests at upper and lower CPP limits; data logging verification (cycle-level records, alarm log format, export function to CSV and OPC-UA); cleaning procedure verification.<\/p>\n<\/div>\n<\/div>\n Performance Qualification \u2014 3\u20135 weeks<\/strong><\/p>\n Three consecutive commercial-speed production runs (1,000\u20133,000 containers each) with commercial resin and preform. CQA verification: wall thickness, neck finish T\/E\/H\/S dimensions, container weight, top-load resistance, AA headspace content. Statistical process capability Cpk \u2265 1.33 calculated across all three runs combined. Batch record completeness review: 100% cycle coverage of CPP data confirmed.<\/p>\n<\/div>\n<\/div>\n ISO 14644-1 class requirements by pharmaceutical production type \u2014 and what each class demands of the machine<\/p>\n<\/div>\n<\/div>\n The environmental classification of the blow molding production area is determined by the type of pharmaceutical product being packaged, not by the blow molding machine’s own specification. For oral solid dosage (OSD) products \u2014 tablets, capsules, powders \u2014 the blow molding area is classified at ISO 14644-1 Class 8 (equivalent to EU GMP Grade D). Class 8 permits a maximum of 3,520,000 particles \u22650.5 \u00b5m per cubic meter of air, and does not impose special requirements on operator gowning beyond standard pharmaceutical site practice. The machine installation in a Class 8 area requires: the machine’s exhaust air (from electrical cabinet cooling and mechanical ventilation) to be directed away from open container conveyance lines and the filling area; standard electrical cabinet construction (IP54 or equivalent); and NSF H1 lubrication throughout as described above.<\/p>\n For liquid oral pharmaceutical products \u2014 syrups, suspensions, oral solutions \u2014 production typically takes place in ISO Class 7 (EU GMP Grade C), which permits a maximum of 352,000 particles \u22650.5 \u00b5m per cubic meter of air. In a Class 7 environment, the machine installation requirements escalate: the electrical cabinet must be sealed and positively pressured from a HEPA-filtered supply air line (maintaining the cabinet interior at a slight positive pressure relative to the room, to prevent room air infiltration during thermal cycling of the cabinet); particulate monitoring must be documented at defined measurement points around the machine per ISO 14644-1; and the machine’s mechanical design must not expose any open grease fittings, unsealed bearings, or open-structure mechanisms above the container production zone. The HGA.ES series meets these requirements without field modification \u2014 the enclosed linear bearing assemblies and sealed ball screw drives described in Section 2 are designed for Class 7 installation as a standard configuration.<\/p>\n For ophthalmic containers (eye drops, contact lens solutions), the production area classification is ISO Class 7\u20138 depending on the filling operation, but the blow molding station itself is typically classified at Grade D (ISO Class 8) because the containers are rinsed with Water for Injection (WFI) or filtered water after blow molding and before filling, regardless of the blow mold cleanliness. The rinsing step is the engineering control that bridges the gap between the blow molding environment (not sterile, not aseptic) and the filling environment (aseptic, ISO Class 5 fill zone within an ISO Class 7 background). The machine’s role in the ophthalmic production chain is to produce dimensionally accurate, particulate-free containers with a smooth inner surface \u2014 the WFI rinse removes any residual particles introduced during the blow cycle before the container enters the aseptic filling zone.<\/p>\n Container sterilization is a downstream operation, not a machine function<\/strong><\/p>\n The HGA.ES machine produces containers that are not sterile at the point of ejection. The blow molding environment is classified at Grade D or Grade C \u2014 not at the aseptic standard required for sterile pharmaceutical products. For sterile liquid products filled into PET containers, a validated container sterilization step \u2014 hydrogen peroxide vapor (H\u2082O\u2082 VHP), gamma irradiation at 25 kGy, or ethylene oxide (ETO) \u2014 is required between blow molding and filling. Each sterilization method has a different impact on PET container properties: H\u2082O\u2082 VHP does not affect PET dimensions or mechanical properties at typical pharmaceutical concentrations; gamma irradiation at 25 kGy produces minor yellowing (\u0394YI 0.5\u20131.5) and a slight IV reduction (\u2248 \u22120.03 dL\/g); ETO leaves trace residuals that require a documented degassing period. The machine specification and qualification are independent of the sterilization method chosen \u2014 the sterilization process is validated separately.<\/p>\n<\/div>\n<\/div>\n <\/p>\n <\/p>\n Installing a pharmaceutical bottle blow molding line?<\/p>\n Request the HGA.ES medicine bottle series IQ documentation package before purchase \u2014 review material certificates, instrument calibration status, and FAT records to assess qualification support before committing to the installation timeline.<\/p>\n |
![\"IQ_OQ_PQ](\"https:\/\/ever-powers.com\/wp-content\/uploads\/2026\/08\/IQ_OQ_PQ-and-Cleanroom-Installation-Instructions-1024x575.webp\" "\\"\\"")
<\/p>\n